1. Medicines transparency at the European Medicines Agency (EMA) in the new information age: the perspectives of patients. Issue 9 (20th October 2016) Authors: Way, Dominic; Bouder, Frederic; Löfstedt, Ragnar; Evensen, Darrick Journal: Journal of risk research Issue: Volume 19:Issue 9(2016) Page Start: 1185 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Transparency and trust in the European pharmaceutical sector: a Commentary. Issue 9 (20th October 2016) Authors: Lofstedt, Ragnar; Way, Dominic Journal: Journal of risk research Issue: Volume 19:Issue 9(2016) Page Start: 1120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Transparency and trust in the European pharmaceutical sector: outcomes from an experimental study. Issue 9 (20th October 2016) Authors: Löfstedt, Ragnar; Way, Dominic Journal: Journal of risk research Issue: Volume 19:Issue 9(2016) Page Start: 1082 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Transparency in Europe: A Quantitative Study. Issue 7 (1st May 2015) Authors: Bouder, Frederic; Way, Dominic; Löfstedt, Ragnar; Evensen, Darrick Journal: Risk analysis Issue: Volume 35:Issue 7(2015) Page Start: 1210 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Transparency of medicines data and safety issues–a European/US study of doctors' opinions: what does the evidence show?. Issue 9 (20th October 2016) Authors: Löfstedt, Ragnar; Way, Dominic; Bouder, Frederic; Evensen, Darrick Journal: Journal of risk research Issue: Volume 19:Issue 9(2016) Page Start: 1172 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗